• head_banner_01

Good User Reputation for Non Protein Amino Acids - Impurities of Amino Acid Used for Synthesize Protein – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

"Based on domestic market and expand abroad business" is our enhancement strategy for Famciclovir, Copper Acetate, Trisodium Acetate, Our group members are goal to provides merchandise with significant performance cost ratio to our consumers, as well as target for all of us is usually to satisfy our consumers from all around the environment.
Good User Reputation for Non Protein Amino Acids - Impurities of Amino Acid Used for Synthesize Protein – Gentolex Detail:

Product Detail

NO

Products

CAS No

Key Quality Indicator

Purity

Max.

impurity

Total solvent residue

Moisture

1

Fmoc-β-Ala-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

Fmoc-D-Ala-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

Fmoc-β-Ala-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

Fmoc-Arg(pbf)-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

Fmoc-β-Ala-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

Fmoc-β-Ala-D-Arg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

Fmoc-β-Ala-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

Fmoc-Asn(Trt)-Asn(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

Fmoc-β-Ala-Asn(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

Fmoc-Asp(OtBu)-Asp(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

Fmoc-β-Ala-Asp(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

Fmoc-Cys(Trt)-Cys(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

Fmoc-β-Ala-Cys(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

Fmoc-Cys(Acm)-Cys(Acm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

Fmoc-β-Ala-Cys(Acm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

Fmoc-Gln(Trt)-Gln(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

Fmoc-β-Ala-Gln(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

Fmoc-Glu(OtBu)-Glu(OtBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

Fmoc-β-Ala-Glu(OtBu)-OH.H2O

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

Fmoc-β-Ala-Gly-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

Fmoc-His(Trt)-His(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

Fmoc-β-Ala-His(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

Fmoc-Ile-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

Fmoc-β-Ala-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

Fmoc-Leu-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

Fmoc-β-Ala-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

Fmoc-D-Leu-D-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

Fmoc-β-Ala-D-Leu-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

Fmoc-Lys(Boc)-Lys(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

Fmoc-β-Ala-Lys(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

Fmoc-Lys(Alloc)-Lys(Alloc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

Fmoc-β-Ala-Lys(Alloc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

Fmoc-Met-Met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

Fmoc-β-Ala-Met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

Fmoc-Orn(Boc)-Orn(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

Fmoc-β-Ala-Orn(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

Fmoc-Phe-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

Fmoc-β-Ala-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

Fmoc-D-Phe-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

Fmoc-β-Ala-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

Fmoc-Pro-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

Fmoc-β-Ala-Pro-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

Fmoc-Ser(tBu)-Ser(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

Fmoc-β-Ala-Ser(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

Fmoc-Ser(Trt)-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

Fmoc-β-Ala-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

Fmoc-Thr(tBu)-Thr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

Fmoc-β-Ala-Thr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

Fmoc-Trp(Boc)-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

Fmoc-β-Ala-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

Fmoc-β-Ala-D-Trp(Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

Fmoc-Tyr(tBu)-Tyr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

Fmoc-β-Ala-Tyr(tBu)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

Fmoc-β-Ala-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

Fmoc-Tyr(Me)-Tyr(Me)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

Fmoc-β-Ala-Tyr(Me)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

Fmoc-Val-Val-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

Fmoc-β-Ala-Val-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

Fmoc-D-Cit-D-Cit-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

Fmoc-β-Ala-D-Cit-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

Fmoc-β-Ala-Dab-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

Fmoc-(3-(2-naphthyl)-D-Ala)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

Fmoc-(4-chloro-D-Phe)2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

Fmoc-β-Ala-4-chloro-D-Phe-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

Fmoc-(D-4Aph(tBuCbm))2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

Fmoc-β-Ala-D-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

Fmoc-β-Ala-Aph(L-Hor)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

Fmoc-β-Ala-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

Fmoc-β-Ala-AEEA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

Fmoc-Aib-Aib-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

Fmoc-β-Ala-Aib-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

Fmoc-Arg-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-Arg(pbf)-OH

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

Fmoc-D-Arg-OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

H-D-Arg(pbf)-OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

Fmoc-HomoArg-OH.HCl

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

Fmoc-D-HomoArg-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

H-D-HomoArg(pbf)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

Fmoc-Asn-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-Asn(Trt)-OH

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

Fmoc-Asp-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-Asp(OtBu)-OH

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

Fmoc-Cys-OH

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-Cys(Trt)-OH

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-Cys(Acm)-OH.HCl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

Fmoc-Gln-OH

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-Gln(Trt)-OH

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

Fmoc-Glu-OH

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-Glu(OtBu)-OH.H2O

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

Fmoc-His-OH

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-His(Trt)-OH

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-His-OH

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

Fmoc-Lys-OH

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-Lys(Boc)-OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-Lys(Alloc)-OH

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

Fmoc-Orn-OH.HCl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

H-Orn(Boc)-OH

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

Fmoc-Ser-OH

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-Ser(tBu)-OH

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-Ser(Trt)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

Fmoc-Thr-OH.H2O

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-Thr(tBu)-OH

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

Fmoc-Trp-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-Trp(Boc)-OH

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

Fmoc-D-Trp-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

H-D-Trp(Boc)-OH

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

Fmoc-Tyr-OH

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-Tyr(tBu)-OH

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

Fmoc-D-Tyr-OH

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

H-D-Tyr(Et)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-Tyr(Me)-OH.HCl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

Fmoc-D-4Aph(Cbm)-OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

H-D-4Aph(tBuCbm)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

Fmoc-Lys(iPr)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-Lys(iPr,Boc)-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

About

Compensation

Gentolex provide great quality products, if any product quality is raised by the client within the required time frame with sufficient evidences, we will provide necessary analysis and evaluation to trigger the procedures of compensations.

Production

The capacities of pharmaceutical products reached tons grade, the capacities of chemical products reach 100tons+ grade, the capabilities are well equipped to serve clients worldwide.

Research and Development

Every year, there is plan set up by the R&D team to develop different new products, when targets set, every member in the team will have to carry on with KPI responsibility and with incentive policy.


Product detail pictures:

Good User Reputation for Non Protein Amino Acids - Impurities of Amino Acid Used for Synthesize Protein – Gentolex detail pictures


Related Product Guide:

We are experienced manufacturer. Wining the majority from the crucial certifications of its market for Good User Reputation for Non Protein Amino Acids - Impurities of Amino Acid Used for Synthesize Protein – Gentolex , The product will supply to all over the world, such as: Honduras, Czech, Greenland, Our company upholds the spirit of "innovation, harmony, team work and sharing, trails, pragmatic progress". Give us a chance and we will prove our capability. With your kind help, we believe that we can create a bright future with you together.
  • Good quality and fast delivery, it's very nice. Some products have a little bit problem, but the supplier replaced timely, overall, we are satisfied.
    5 Stars By Matthew from Peru - 2018.12.14 15:26
    The factory technical staff not only have high level of technology, their English level is also very good, this is a great help to technology communication.
    5 Stars By Michaelia from Grenada - 2017.11.01 17:04
    Write your message here and send it to us